Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Radiation Injuries, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT04659343 2025-03-05

TDM for Optimized Outcome in Patients With mRCC.

Recruiting

200 enrolled

Genitourinary

Kidney Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05652673 2025-02-28

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Phase NA Recruiting

80 enrolled

Dermatologic

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT05355168 2024-12-31

Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma

Phase 2 Completed

35 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Drug-Related Side Effects and Adverse Reactions

NCT06302062 2024-12-03

TAL-T

Phase 1 Recruiting

23 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT06407401 2024-11-05

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

Phase 3 Not yet recruiting

399 enrolled

Breast

Breast Neoplasms, Musculoskeletal Pain, Drug-Related Side Effects and Adverse Reactions

NCT06558084 2024-08-16

Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy

Completed

64 enrolled

Breast

Breast Neoplasms, Disease Progression, Drug-Related Side Effects and Adverse Reactions

NCT04696081 2024-08-09

AFIB-CANCER

Recruiting

1,000 enrolled

Atrial Fibrillation, Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT06483685 2024-07-03

RADIANTS

Active not recruiting

500,000 enrolled

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05838638 2024-05-16

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Phase NA Recruiting

610 enrolled

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT04824352 2024-05-14

AIEO

Phase 2 Suspended

44 enrolled

Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT05022797 2024-05-13

Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS

Phase 2 Terminated

3 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse, Drug-Related Side Effects and Adverse Reactions

NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

Unknown

1,000 enrolled

GenitourinaryOther hematologic neoplasmSarcoma

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

NCT06291688 2024-03-04

Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability

Phase NA Unknown

110 enrolled

Neoplasms, Neoplasms, Second Primary, Drug-Related Side Effects and Adverse Reactions

NCT05717699 2024-02-28

Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma

Phase 1 Recruiting

18 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Drug-Related Side Effects and Adverse Reactions

NCT05717712 2024-02-28

Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma

Phase 1 Recruiting

18 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Drug-Related Side Effects and Adverse Reactions

NCT06216639 2024-02-09

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

Unknown

2,000 enrolled

Gastrointestinal

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT03638375 2023-12-12

ACTME

Phase 1/2 Unknown

34 enrolled

Dermatologic

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT05137847 2023-12-12

A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

Completed

118 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Drug-Related Side Effects and Adverse Reactions

NCT06152471 2023-11-30

ASF-BC

Phase 3 Unknown

100 enrolled

Breast

Breast Neoplasms, Diarrhea, Drug-Related Side Effects and Adverse Reactions

NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Phase 2 Terminated

17 enrolled 7 charts

CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00052884 2023-06-18

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

Phase 1 Terminated

8 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

NCT03882580 2023-04-24

NEOCARDIO

Unknown

5,000 enrolled

Heart Diseases, Heart Failure, Metabolic Diseases, Vascular Diseases, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT04279470 2023-04-13

CARTABLE

Completed

100,000 enrolled

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05800054 2023-04-05

Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer

Phase NA Recruiting

210 enrolled

Gastrointestinal

Esophageal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04138381 2023-03-27

SeliGIST

Phase 1/2 Unknown

30 enrolled

Sarcoma

Neoplasm Metastasis, Sarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04770922 2023-02-16

Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

Completed

80 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00003407 2023-02-02

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Phase 2 Withdrawn

MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute, Drug-Related Side Effects and Adverse Reactions

NCT05266300 2022-11-01

Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.

Completed

722 enrolled

BreastGastrointestinal

Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05472350 2022-07-25

Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy

Phase NA Unknown

128 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Cough, Drug-Related Side Effects and Adverse Reactions

Clinical Trials

Real World Asparaginase Therapy Toxicity

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients

PCT

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

IMMUNO-FIT Observational Study

MPGx-INDALL

A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects

MIZAR-002

MIZAR-001

Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib

Neutropenia With TNF-α Inhibitors

CCT2

IPGx Registry

Pharmaceutical Care for Patients Using Capecitabine

Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors

CARTIER

TDM for Optimized Outcome in Patients With mRCC.

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma

TAL-T

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy

AFIB-CANCER

RADIANTS

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

AIEO

Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability

Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma

Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

ACTME

A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

ASF-BC

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

NEOCARDIO

CARTABLE

Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer

SeliGIST

Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.

Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy